In the News
Cambia’s Peggy Maguire: Palliative Care Supports Economic Sustainability
Peggy Maguire, president of Cambia Health Foundation, shares how Cambia worked with GNS to use predictive analytics and identify members of Cambia's Medicare Advantage population that could benefit from an extra layer of support. Read the full article here.
read more
Study: If more Wisconsin doctors provided better care, key medical procedures would cost 30% less
The Milwaukee Journal Sentinel covers the results of a collaboration between the Wisconsin Business Group on Health and GNS Healthcare in identifying the impact of provider optimization on cost. Read the article!
read more
Harvard Business Review: Using AI to Understand What Causes Diseases
Sema Sgaier and Francesca Domini of Surgo Foundation share how they causal AI can bring new clarity to understanding the underlying cause of disease. Read the full article here.
read moreEvents
Colin Hill to Speak at MassBio’s State of Possible Conference
This year’s State of Possible Conference, MassBio's Annual Meeting, will celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate...
read more
Iya Khalil to Weigh in on How AI is Transforming Early-Stage Biotech Partnerships and Drug Discovery
Artificial Intelligence (AI) and Machine Learning (ML) are rapidly transforming industries, from autonomous cars, to logistics, to technology – and now biotechnology. Excitement about AI and ML driven solutions for accelerated drug discovery, drug development, and...
read more
GNS Co-founders to speak at Elsevier’s first AI and Big Data in Cancer Conference
The future of medicine is data-driven and AI-enabled. Artificial intelligence will impact diagnosis, treatment decisions and patient care. Learn from others along the value-chain to understand how to effectively translate technology, data and analytic innovations into...
read morePress Releases
GNS Healthcare and Collaborators Identify PHF19 as Marker of Aggressive Multiple Myeloma Progression
Study results are from the DREAM Challenge and are published in Leukemia CAMBRIDGE, Mass.– May 28, 2020 – GNS Healthcare (GNS), a leading AI-driven precision medicine, announced results of a recently published collaboration that uncovered transcription factor PHF19 as...
read moreIndustry Luminaries Across Biopharmaceuticals, Payers, and Technology Convene on GNS Healthcare’s In Silico Patient Advisory Board
Michael Bonney, Tom Daniel, Peter Neupert, and Lee Newcomer join GNS Healthcare’s in silico Patient Advisory Board Cambridge, MA – April 21, 2020 – GNS Healthcare, an AI-driven precision medicine company, is pleased to announce the formation of its in silico Patient...
read moreGNS Healthcare Welcomes Earl Steinberg as Chief of Health Plan Division
CAMBRIDGE, Mass.– April 14, 2020 – GNS Healthcare (GNS) is pleased to announce that Dr. Earl Steinberg, a nationally recognized expert in population health management, data analytics, and clinical informatics, has joined the company’s leadership team as a consultant...
read more